Summary
Latest filing:
Rupert Vessey files SEC Form 4 reports at Generate Biomedicines, Inc. (GENB). 3 SEC Form 4 filings on record going back to 2024, most recently on 2 March 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Rupert Vessey has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Rupert Vessey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Noubar Afeyan - $75.00M of GENB open-market activity in the last 12 months
- Amy E. Herr - $437K of TECH open-market activity in the last 12 months
- Michael Nally - $240K of GENB open-market activity in the last 12 months
- Jason Silvers - $32K of GENB open-market activity in the last 12 months
- Jane L. Mendillo - $24K of GENB open-market activity in the last 12 months
- Frances Arnold - $16K of GENB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Rupert Vessey?
Rupert Vessey is a corporate insider of Generate Biomedicines, Inc. (GENB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Rupert Vessey last file a Form 4?
The most recent primary Form 4 on record is dated 2 March 2026, one of 3 filings going back to 2024.
Where can I see all of Rupert Vessey's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Rupert Vessey and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
